165 related articles for article (PubMed ID: 11023708)
1. Etoposide encapsulated in positively charged liposomes: pharmacokinetic studies in mice and formulation stability studies.
Sengupta S; Tyagi P; Velpandian T; Gupta YK; Gupta SK
Pharmacol Res; 2000 Nov; 42(5):459-64. PubMed ID: 11023708
[TBL] [Abstract][Full Text] [Related]
2. Encapsulation in cationic liposomes enhances antitumour efficacy and reduces the toxicity of etoposide, a topo-isomerase II inhibitor.
Sengupta S; Tyagi P; Chandra S; Kochupillai V; Gupta SK
Pharmacology; 2001; 62(3):163-71. PubMed ID: 11287818
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics and tissue distribution of liposomal etoposide in rats.
Sistla A; Smith DJ; Kobrinsky NL; Kumar K
Drug Deliv; 2009 Nov; 16(8):423-9. PubMed ID: 19839786
[TBL] [Abstract][Full Text] [Related]
4. Liposomal topotecan formulation with a low polyethylene glycol grafting density: pharmacokinetics and antitumour activity.
Li C; Wang C; Yang H; Zhao X; Wei N; Cui J
J Pharm Pharmacol; 2012 Mar; 64(3):372-82. PubMed ID: 22309269
[TBL] [Abstract][Full Text] [Related]
5. Development of etoposide-loaded bovine serum albumin nanosuspensions for parenteral delivery.
Wang Z; Li Z; Zhang D; Miao L; Huang G
Drug Deliv; 2015 Jan; 22(1):79-85. PubMed ID: 24401038
[TBL] [Abstract][Full Text] [Related]
6. Liposomal and nonliposomal drug pharmacokinetics after administration of liposome-encapsulated vincristine and their contribution to drug tissue distribution properties.
Krishna R; Webb MS; St Onge G; Mayer LD
J Pharmacol Exp Ther; 2001 Sep; 298(3):1206-12. PubMed ID: 11504822
[TBL] [Abstract][Full Text] [Related]
7. The effect of PEG coating on in vitro cytotoxicity and in vivo disposition of topotecan loaded liposomes in rats.
Dadashzadeh S; Vali AM; Rezaie M
Int J Pharm; 2008 Apr; 353(1-2):251-9. PubMed ID: 18191511
[TBL] [Abstract][Full Text] [Related]
8. [Preparation and in vitro and in vivo evaluation of etoposide submicro-emulsion for intravenous injection].
Tian LL; Tang X; He HB; Wang J
Yao Xue Xue Bao; 2007 Aug; 42(8):892-7. PubMed ID: 17944242
[TBL] [Abstract][Full Text] [Related]
9. A lyophilized etoposide submicron emulsion with a high drug loading for intravenous injection: preparation, evaluation, and pharmacokinetics in rats.
Chen H; Shi S; Zhao M; Zhang L; He H; Tang X
Drug Dev Ind Pharm; 2010 Dec; 36(12):1444-53. PubMed ID: 21050136
[TBL] [Abstract][Full Text] [Related]
10. Effect of high-dose cyclosporine on etoposide pharmacodynamics in a trial to reverse P-glycoprotein (MDR1 gene) mediated drug resistance.
Lum BL; Kaubisch S; Fisher GA; Brown BW; Sikic BI
Cancer Chemother Pharmacol; 2000; 45(4):305-11. PubMed ID: 10755319
[TBL] [Abstract][Full Text] [Related]
11. Toxicity, stability and pharmacokinetics of amphotericin B in immunomodulator tuftsin-bearing liposomes in a murine model.
Khan MA; Owais M
J Antimicrob Chemother; 2006 Jul; 58(1):125-32. PubMed ID: 16709592
[TBL] [Abstract][Full Text] [Related]
12. [Pharmacokinetic aspects of oral administration of etoposide].
Tillmann B; Krümpelmann S; Würthwein G; Wagner A; Schulze-Westhoff P; Hempel G; Jürgens H; Boos J
Klin Padiatr; 1998; 210(4):159-64. PubMed ID: 9743946
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics and tissue distribution of etoposide delivered in long circulating parenteral emulsion.
Reddy PR; Venkateswarlu V
J Drug Target; 2005 Dec; 13(10):543-53. PubMed ID: 16390815
[TBL] [Abstract][Full Text] [Related]
14. Formulation of plumbagin loaded long circulating pegylated liposomes: in vivo evaluation in C57BL/6J mice bearing B16F1 melanoma.
Kumar MR; Aithal BK; Udupa N; Reddy MS; Raakesh V; Murthy RS; Raju DP; Rao BS
Drug Deliv; 2011; 18(7):511-22. PubMed ID: 21793763
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of paclitaxel-containing liposomes in rats.
Fetterly GJ; Straubinger RM
AAPS PharmSci; 2003 Nov; 5(4):E32. PubMed ID: 15198520
[TBL] [Abstract][Full Text] [Related]
16. Influence of administration route on tumor uptake and biodistribution of etoposide loaded solid lipid nanoparticles in Dalton's lymphoma tumor bearing mice.
Harivardhan Reddy L; Sharma RK; Chuttani K; Mishra AK; Murthy RS
J Control Release; 2005 Jul; 105(3):185-98. PubMed ID: 15921775
[TBL] [Abstract][Full Text] [Related]
17. Prolonged release biodegradable vesicular carriers for rifampicin--formulation and kinetics of release.
Kamath MP; Shenoy BD; Tiwari SB; Karki R; Udupa N; Kotian M
Indian J Exp Biol; 2000 Feb; 38(2):113-8. PubMed ID: 11218826
[TBL] [Abstract][Full Text] [Related]
18. Preparation, characterisation and biodistribution of 99mTc-labeled liposome encapsulated cyclosporine.
Arulsudar N; Subramanian N; Mishra P; Sharma RK; Murthy RS
J Drug Target; 2003 Apr; 11(3):187-96. PubMed ID: 13129826
[TBL] [Abstract][Full Text] [Related]
19. Etoposide loaded solid lipid nanoparticles for curtailing B16F10 melanoma colonization in lung.
Athawale RB; Jain DS; Singh KK; Gude RP
Biomed Pharmacother; 2014 Mar; 68(2):231-40. PubMed ID: 24560352
[TBL] [Abstract][Full Text] [Related]
20. Enhanced delivery of etoposide to Dalton's lymphoma in mice through polysorbate 20 micelles.
Reddy LH; Sharma RK; Murthy RR
Acta Pharm; 2006 Jun; 56(2):143-55. PubMed ID: 16613722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
